Cardiovascular
The circulatory system is a vast network of organs and vessels that is responsible for the flow of blood, nutrients, oxygen and other gases, and hormones to and from cells. The system consists of three independent systems that work together: the heart (cardiovascular), lungs (pulmonary), and arteries, veins, coronary and portal vessels (systemic). Together, the heart, blood, and blood vessels make up the cardiovascular component of the circulatory system. It includes the pulmonary circulation, a "loop" through the lungs where blood is oxygenated. It also incorporates the systemic circulation, which runs through the rest of the body to provide oxygenated blood.
Because of its vastness and critical nature, the circulatory system is one of the systems of the body most prone to disease. Disorders of this system are the leading cause of death among adults in the majority of countries world-wide, arteriosclerosis being one of the most common diseases. It is characterized by fatty deposits in the arteries that cause the walls to stiffen and thicken the walls, and may result in restricted blood flow and ischemia. This may result in symptoms such as angina and dyspnea, necrosis, and ultimately in heart attack or stroke. Hypertension, another circulatory is disease, causes the heart to work harder and can lead to complications as a heart attack, a stroke, or kidney failure. Abnormal blood lipid levels, that is high total cholesterol, high levels of triglycerides, high levels of low-density lipoprotein or low levels of high-density lipoprotein (HDL) cholesterol all increase the risk of heart disease and stroke, and are of particular interest of modern research. Besides changing food intake habits of patients suffering from cardiovascular diseases, in combination with the stimulation to increase physical exercise, special medication may also modify a patients blood lipid profile and prevent the person from developing life threatening circulatory diseases.
Axon ID | Name | Description | From price | |
---|---|---|---|---|
3488 | (±)-CGP-12177A | β1/β2 adrenoceptor antagonist, β3 adrenoceptor agonist | €120.00 | |
1190 | 2-Chloroadenosine | Adenosine A1 and A2A agonist | €65.00 | |
1188 | Adenosine amine congener | Adenosine A1 agonist | €125.00 | |
2275 | AdipoRon | Orally active small-molecule AdipoR agonist | €80.00 | |
1207 | Amthamine dihydrobromide | H2 agonist | €90.00 | |
2191 | AR 244555 | Inverse agonist of Mas G-protein signaling | €125.00 | |
3386 | AVE0991 | Selective and orally active Mas receptor agonist | €150.00 | |
1154 | B-HT 933 dihydrochloride | α2 adrenoceptor agonist | €120.00 | |
2317 | BAY 60-6583 | Potent and highly selective A2BAR (Adenosine) agonist | €125.00 | |
1157 | Bromobuterol | β2 agonist | €85.00 | |
1969 | Buloxibutid | First non-peptide selective AT2 receptor agonist | Inquire | |
1319 | CGS 21680 hydrochloride | Adenosine A2A agonist | €95.00 | |
2015 | CP 945598 | CB1 antagonist | €135.00 | |
2119 | CP 945598 hydrochloride | CB1 antagonist | €135.00 | |
1324 | Dimaprit dihydrochloride | H2 agonist | €45.00 | |
1445 | Dimebon | Alzheimer's disease therapeutic | €60.00 | |
2050 | Eletriptan hydrobromide | Selective 5-HT1B/1D receptor agonist | €90.00 | |
2146 | Fedovapagon | Selective vasopressin V2 receptor agonist | €140.00 | |
1485 | Fingolimod | S1PR1 agonist; Immunosuppressant | €60.00 | |
2247 | Flumethasone pivalate | Topical glucocorticoid receptor agonist | €60.00 | |
1287 | GR 79236 | Adenosine A1 agonist | €120.00 | |
2363 | GSK 2033 | The first potent cell-active LXR antagonist | €105.00 | |
2781 | HS666 hydrochloride | Kappa-opioid partial agonist | €135.00 | |
3654 | Isoprenaline hydrochloride | β1/β2 adrenoceptor agonist | €50.00 | |
1615 | KRP203 | S1PR1 agonist | €145.00 | |
3774 | LN6023 dihydrochloride | First-in-class, selective ACKR3/CXCR7 superagonist | €150.00 | |
2357 | LXR 623 | Partial agonist of Liver X Receptor | €95.00 | |
2657 | MGL-3196 | Oral, liver-targeted, selective thyroid hormone receptor β-agonist | €90.00 | |
2414 | Mirabegron | Highly selective and orally active agonist of the human β3-adrenoceptor | €120.00 | |
1296 | Modafinil | α1 adrenoceptor agonist | €60.00 |